Search Results 1521-1530 of 16893 for monoclonal antibody

1. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

   Positive for hepatitis C antibody, hepatitis B surface antigen, or human immunodeficiency virus (HIV) antibody. Clinically significant thrombocytopenia ...

2. Study of Pomalidomide and Low Dose Dexamethasone With or Without Pembrolizumab (MK-3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (MK-3475-183/KEYNOTE-183) - Mayo Clinic

   ... antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell costimulation or checkpoint pathways); Is pregnant or breast ...

3. CAR-T Cell Therapy Program - Department home - Mayo Clinic

   Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...

4. A Study to Analyze CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma - Mayo Clinic

   Received treatment with a Food and Drug Administration approved PD-1 blocking antibody for 12 weeks or longer;; Have PD (according to RECIST v1.1) within 12 ...

5. Infectious Diseases - Clinical trials

   ... antibodies against microorganisms, and inflammatory markers (e.g., leukocyte esterase, CRP) in synovial fluid for the diagnosis of prosthetic joint ...

6. Health Topics - Mayo Clinic News Network

   Herd immunity, antibodies & COVID-19 / bile duct cancer / peripheral artery disease. Jennifer O'Hara. August 2, 2020. Health & Wellness. Safety measures before ...

7. Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA) - Mayo Clinic

   ... antibody. Read More on PubMed. Additional contact information. Cancer-related trials contact form. Phone: 855-776-0015 (toll-free). International patient ...

8. A Study to Evaluate MUC1 Vaccine to Prevent Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer - Mayo Clinic

   The purpose of this study is to evaluate immunogenicity of the vaccine, assessed at week 12, based on the increase in IgG anti-MUC1 antibody titer over the ...

9. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

   ... antibody and anthracycline containing first-line therapy for disease under study. Note: The time of relapse is calculated from the date of the first disease ...

10. TD-1473 for Active Ulcerative Colitis (UC) - Clinical Trials

    Subjects with positive hepatitis B virus core antibody are excluded only if they have concurrent negative hepatitis B surface antibody or detectable serum ...